logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > BI-847325 CAS 1207293-36-4

BI-847325 CAS 1207293-36-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1207293-36-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1207293-36-4
Appearance::
Crystalline Solid
Molecular Formula::
C29H28N4O2
Molecular Weight::
464.55800
EINECS NO::
NA
MDL NO::
NA
CAS NO::
1207293-36-4
Appearance::
Crystalline Solid
Molecular Formula::
C29H28N4O2
Molecular Weight::
464.55800
EINECS NO::
NA
MDL NO::
NA
BI-847325 CAS 1207293-36-4

Product Description:

Product Name: BI-847325 CAS NO: 1207293-36-4

 

 

Synonyms:

3-[3-[[[4-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indol-6-yl]-N-ethyl-2-propynamide;

 

 

Chemical & Physical Properties:

Appearance: Crystalline solid

Assay :≥98.0%

Density: 1.3±0.1 g/cm3

Index of Refraction: 1.673

Storage: 3 years -20℃ powder; 6 months -80℃ in solvent.

 

 

BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor with IC50 of 3 nM, 25 nM, 15 nM, 25 nM, and 4 nM for Xenopus laevis Aurora B, human Aurora A and Aurora C, as well as human MEK1 and MEK2, respectively.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.